Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-1459
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis ; day:28 ; month:2 ; year:2019 ; pages:1-12
Journal of neurology ; (28.2.2019), 1-12

Creator
Turner, Benjamin
Cree, Bruce A. C.
Kappos, Ludwig
Montalban, Xavier
Papeix, Caroline
Wolinsky, Jerry S.
Buffels, Regine
Fiore, Damian
Garren, Hideki
Han, Jian
Hauser, Stephen L.
Contributor
SpringerLink (Online service)

DOI
10.1007/s00415-019-09248-6
URN
urn:nbn:de:101:1-2019032520524341540354
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Turner, Benjamin
  • Cree, Bruce A. C.
  • Kappos, Ludwig
  • Montalban, Xavier
  • Papeix, Caroline
  • Wolinsky, Jerry S.
  • Buffels, Regine
  • Fiore, Damian
  • Garren, Hideki
  • Han, Jian
  • Hauser, Stephen L.
  • SpringerLink (Online service)

Other Objects (12)

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis

Postural Control in Relapsing-Remitting Multiple Sclerosis

Postural Control in Relapsing-Remitting Multiple Sclerosis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Serum prolactin in patients with relapsing remitting multiple sclerosis

Serum prolactin in patients with relapsing remitting multiple sclerosis

Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis

Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis

Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree

Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis

Related objects